These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9804181)

  • 1. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures.
    van Roozendaal CE; Gillis AJ; Klijn JG; van Ooijen B; Claassen CJ; Eggermont AM; Henzen-Logmans SC; Oosterhuis JW; Foekens JA; Looijenga LH
    FEBS Lett; 1998 Oct; 437(1-2):107-11. PubMed ID: 9804181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
    Yballe CM; Vu TH; Hoffman AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma.
    Albrecht S; Waha A; Koch A; Kraus JA; Goodyer CG; Pietsch T
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1270-6. PubMed ID: 8957451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma.
    Kim KS; Lee YI
    Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.
    Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R
    Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
    Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
    Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
    Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
    Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
    Wada M; Seeger RC; Mizoguchi H; Koeffler HP
    Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic imprinting of IGF2 and H19 in human meningiomas.
    Müller S; Zirkel D; Westphal M; Zumkeller W
    Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
    Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
    Fukuzawa R; Umezawa A; Ochi K; Urano F; Ikeda H; Hata J
    Int J Cancer; 1999 Aug; 82(4):490-7. PubMed ID: 10404060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory mechanisms at the mouse Igf2/H19 locus.
    Kaffer CR; Grinberg A; Pfeifer K
    Mol Cell Biol; 2001 Dec; 21(23):8189-96. PubMed ID: 11689707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
    Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
    Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
    Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
    Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific expression and total expression levels of imprinted genes during early mouse development: implications for imprinting mechanisms.
    Szabó PE; Mann JR
    Genes Dev; 1995 Dec; 9(24):3097-108. PubMed ID: 8543154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
    Rainho CA; Kowalski LP; Rogatto SR
    Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression.
    Berteaux N; Aptel N; Cathala G; Genton C; Coll J; Daccache A; Spruyt N; Hondermarck H; Dugimont T; Curgy JJ; Forné T; Adriaenssens E
    Mol Cell Biol; 2008 Nov; 28(22):6731-45. PubMed ID: 18794369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of histone acetylation and DNA methylation in the maintenance of the imprinted expression of the H19 and Igf2 genes.
    Pedone PV; Pikaart MJ; Cerrato F; Vernucci M; Ungaro P; Bruni CB; Riccio A
    FEBS Lett; 1999 Sep; 458(1):45-50. PubMed ID: 10518931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic imprinting in the rat: linkage of Igf2 and H19 genes and opposite parental allele-specific expression during embryogenesis.
    Overall M; Bakker M; Spencer J; Parker N; Smith P; Dziadek M
    Genomics; 1997 Oct; 45(2):416-20. PubMed ID: 9344669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Igf2 genomic imprinting in mice induced by 5-azacytidine, an inhibitor of DNA methylation.
    Hu JF; Nguyen PH; Pham NV; Vu TH; Hoffman AR
    Mol Endocrinol; 1997 Dec; 11(13):1891-8. PubMed ID: 9415394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.